A Controlled Trial of Gabapentin in Vulvodynia: Biological Correlates of Response.
Phase of Trial: Phase III
Latest Information Update: 17 Jul 2017
At a glance
- Drugs Gabapentin (Primary)
- Indications Vulvodynia
- Focus Therapeutic Use
- 29 Apr 2016 Status changed from active, no longer recruiting to completed.
- 01 Dec 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 Aug 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.